Lineage price target lowered to $95 from $100 at Morgan Stanley

Morgan Stanley analyst Ronald Kamdem lowered the firm’s price target on Lineage (LINE) to $95 from $100 and keeps an Overweight rating on the shares after updating the firm’s FY24, FY25 and FY26 AFFO estimates.